Staplin, N
111  results:
Search for persons X
?
1

Effects of empagliflozin on progression of chronic kidney d..:

Staplin, N ; Haynes, R ; Judge, PK...
The Lancet Diabetes & Endocrinology.  12 (2024)  1 - p. 39-50 , 2024
 
?
2

Impact of primary kidney disease on the effects of empaglif..:

Judge, PK ; Staplin, N ; Mayne, KJ...
The Lancet Diabetes & Endocrinology.  12 (2024)  1 - p. 51-60 , 2024
 
?
3

WCN23-0342 DETERMINANTS OF THE EFFECTS OF SGLT2i ON PROGRES..:

Staplin, N. ; Haynes, R. ; Herrington, W..
Kidney International Reports.  8 (2023)  3 - p. S472-S473 , 2023
 
?
4

Mendelian randomization study of the relevance of blood pre..:

Turner, M ; Alegre-Diaz, J ; Berumen, J...
European Heart Journal.  44 (2023)  Supplement_2 - p. , 2023
 
?
5

Perioperative rosuvastatin therapy increases creatine kinas..:

Wijesurendra, R ; Sardell, R ; Hill, M...
European Heart Journal.  43 (2022)  Supplement_2 - p. , 2022
 
?
6

Determinants of post-operative atrial fibrillation in 1613 ..:

Wijesurendra, R ; Sardell, R ; Hill, M...
European Heart Journal.  43 (2022)  Supplement_2 - p. , 2022
 
?
12

Effects of empagliflozin on progression of chronic kidney d..:

Staplin, N ; Haynes, R ; Judge, PK...
https://discovery.ucl.ac.uk/id/eprint/10184372/1/1-s2.0-S2213858723003212-main.pdf.  , 2023
 
1-15